Fibroblast Revenue and Competitors
Estimated Revenue & Valuation
- Fibroblast's estimated annual revenue is currently $2.8M per year.
- Fibroblast's estimated revenue per employee is $101,500
Employee Data
- Fibroblast has 28 Employees.
Fibroblast's People
Name | Title | Email/Phone |
---|
Fibroblast Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.4M | 24 | N/A | N/A | N/A |
#2 | $22.7M | 84 | 24% | N/A | N/A |
#3 | $28M | 186 | -15% | $4.7M | N/A |
#4 | $3.1M | 19 | N/A | N/A | N/A |
#5 | $80.4M | 277 | 11% | $46.7M | N/A |
#6 | $58.6M | 452 | -12% | $27.1M | N/A |
#7 | $19M | 136 | 15% | N/A | N/A |
#8 | $5.3M | 28 | N/A | N/A | N/A |
#9 | $0.4M | 6 | N/A | N/A | N/A |
#10 | $6.8M | 0 | N/A | $13.5M | N/A |
#11 | $1.6M | 18 | N/A | N/A | N/A |
#12 | $107.9M | 607 | -15% | $195.3M | $1.6B |
What Is Fibroblast?
N/A
Total Funding
28
Number of Employees
$2.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fibroblast News
2022-04-17 - Steroid-induced fibroblast growth factors drive an epithelial ...
The authors found that patients with severe asthma had increased corticosteroid-driven fibroblast growth factor (FGF) expression.
2022-04-17 - High C-terminal fibroblast growth factor-23 in CKD | IJGM
High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in...
2022-04-13 - Sphingolipids control dermal fibroblast heterogeneity
Human dermal fibroblasts are cell constituents of our skin that display cell-to-cell phenotypic heterogeneity as a result of their dynamic cell...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 28 | N/A | N/A |
#2 | $2.7M | 28 | N/A | N/A |
#3 | $2.8M | 28 | N/A | N/A |
#4 | $4M | 28 | N/A | N/A |
#5 | $2.8M | 28 | N/A | N/A |